Work

Low incidence of extrapyramidal symptoms following treatment with a muscarinic agonist medication for schizophrenia

Year: 2026

Type: review

Source: Schizophrenia Research

DOI: 10.1016/j.schres.2026.03.004

Authors: Steven D. Targum, Carolyn Watson, Amy Claxton, Pierre Nicolas, Keisha D. Novak, Inder Kaul, Stephen R. Marder, Wei-Chih Lin, William P. Horan, Ronald Marcus, Stephen K. Brannan

Institutions: Bristol-Myers Squibb (United States), University of California, Los Angeles, Engrail Therapeutics, Inc. (United States)

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, Apollo

OpenAlex ID: W7135075620

FWCI: 2.3

Cites: 29

Cited by: 2

Related to: 10